+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Over the Counter (OTC) Drugs Market, By Product (Cough, Cold & Flu, Vitamins, Mineral, & Supplements (VMS), Analgesics, Others), By Route of Administration, By Dosage Form, By Distribution Channel, By Region, Competition, Forecast & Opportunities, 2026

  • ID: 5232394
  • Report
  • December 2021
  • Region: Global
  • 115 Pages
  • TechSci Research
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Over the Counter (Otc) Drugs Market is Anticipated to Grow at CAGR of 9.86% Through 2026 to Reach USD 274.15 Billion by the End of Forecast Period, 2026.

FEATURED COMPANIES

  • Bayer AG
  • Cipla Ltd.
  • Johnson & Johnson
  • Mylan NV
  • Novartis AG
  • Perrigo Company Plc.
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Over the Counter (OTC) Drugs Market is anticipated to grow at CAGR of 9.86% through 2026 to reach USD274.15 billion by the end of forecast period, 2026. Future growth of the Global Over the Counter (OTC) Drugs Market can be attributed to increasing demand emanating from the developing countries due to increasing use of these drugs for common disease conditions. Over the counter (OTC) drugs have higher market penetration in developing countries like India, China, Kenya, etc., and as a result there is high affordability and accessibility of OTC drugs.



With increasing healthcare expenditures and surging demand for the effective treatment, growth of the Global Over the Counter (OTC) Drugs Market is evident for next five years. Moreover, online pharmacies are increasing rapidly. Although, the demand for prescription is mandatory for various online platforms, multiple over the counter drugs are available without the prescription from these online pharmacies. Thus, consumers are able to easily order their medicines from the online sources and avoid long queues at the traditional offline pharmacies, thereby supporting the growth of the Global Over the Counter (OTC) Drugs Market in the future five years.

Although, over the counter drugs market lacks classification. With present concerns over ill-monitored dozing and increased drug abusing instances, the Global Over the Counter (OTC) Drugs Market might suffer in the future growth. Proper channeling and maintained distribution of the over the counter drugs may support to overcome the short comings of the market and support future growth in the forecast years.

The OTC drugs market is segmented based on product, route of administration, dosage form, distribution channel, region, and company. Based on route of administration, market can be segregated into oral, parenteral, topical, and others. The oral route of administration is anticipated to hold the largest revenue shares and dominate the market segment in the upcoming five years on the account of its simplicity. Most of the over the counter drugs available in the market are administered orally that may be in capsule, tablet, or syrup form. Also, administration procedure is convenient, and the patient does not require help from patient caretaker for the administration which is a requirement during administering parenteral administration. Parenteral administration is also anticipated to register significant growth in the next five years on the grounds of effectivity of the drugs when administered in parenteral form.

Major players operating in the Global Over the Counter (OTC) Drugs Market include Johnson & Johnson, Bayer AG, Novartis AG, GlaxoSmithKline Plc.-Pfizer, Inc., Sanofi S.A., Perrigo Company Plc., Reckitt Benckiser Group Plc., Sun Pharmaceutical Industries Ltd., The Procter & Gamble Company, Teva Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Zydus Takeda Healthcare Pvt. Ltd., Mylan NV, Cipla Ltd., Alkem Laboratories Limited, and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions.

Years considered for this report:

  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022–2026

Objective of the Study:

  • To analyze the historical growth in the market size of the Global Over the Counter (OTC) Drugs Market from 2016 to 2020.
  • To estimate and forecast the market size of the Global Over the Counter (OTC) Drugs Market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast the Global Over the Counter (OTC) Drugs Market based on product, route of administration, dosage form, distribution channel, region, and company and regional distribution.
  • To identify dominant region or segment in the Global Over the Counter (OTC) Drugs Market.
  • To identify drivers and challenges for the Global Over the Counter (OTC) Drugs Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Over the Counter (OTC) Drugs Market.
  • To identify and analyze the profile of leading players operating in the Global Over the Counter (OTC) Drugs Market.
  • To identify key sustainable strategies adopted by the market players in the Global Over the Counter (OTC) Drugs Market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of manufacturers across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufacturers which could not be identified due to the limitations of secondary research. The publisher analyzed the manufacturers, distribution channels and presence of all major players across the globe.

The publisher calculated the market size of the Global Over the Counter (OTC) Drugs Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:

  • Over the counter drugs manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to over the counter drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:


In this report, the Global Over the Counter (OTC) Drugs Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Over the Counter (OTC) Drugs Market, By Product:

  • Cough, Cold, & Flu,
  • Vitamins, Mineral, & Supplements (VMS)
  • Analgesics
  • Gastrointestinal Products
  • Dermatology Products
  • Others

Over the Counter (OTC) Drugs Market, By Route of Administration:

  • Oral
  • Parenteral
  • Topical
  • Others

Over the Counter (OTC) Drugs Market, By Dosage Form:

  • Tablets
  • Capsules
  • Liquids & Solutions
  • Cream/Lotion/Ointments
  • Others

Over the Counter (OTC) Drugs Market, By Distribution Channel:

  • Retail Pharmacy
  • Hospital Pharmacy
  • E-Pharmacy

Over the Counter (OTC) Drugs Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • France
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Over the Counter (OTC) Drugs Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.
This report will be delivered within 1 business day.

Please note: With the Enterprise license, the PDF product is printable and editable and comes with a market data excel sheet.

Frequently Asked Questions about the Global Over the Counter (OTC) Drugs Market

What is the estimated value of the Global Over the Counter (OTC) Drugs Market?

The Global Over the Counter (OTC) Drugs Market was estimated to be valued at $121.4 Million in 2016.

What is the growth rate of the Global Over the Counter (OTC) Drugs Market?

The growth rate of the Global Over the Counter (OTC) Drugs Market is 8.5%, with an estimated value of $274.2 Million by 2026.

What is the forecasted size of the Global Over the Counter (OTC) Drugs Market?

The Global Over the Counter (OTC) Drugs Market is estimated to be worth $274.2 Million by 2026.

Who are the key companies in the Global Over the Counter (OTC) Drugs Market?

Key companies in the Global Over the Counter (OTC) Drugs Market include Johnson & Johnson, Bayer AG, Novartis AG, GlaxoSmithKline Plc., Pfizer, Inc., Sanofi S.A., Perrigo Company Plc., Reckitt Benckiser Group Plc. and The Procter & Gamble Company.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Cipla Ltd.
  • Johnson & Johnson
  • Mylan NV
  • Novartis AG
  • Perrigo Company Plc.

1. Product Overview2. Research Methodology3. Impact of COVID-19 on Global Over the Counter (OTC) Drugs Market4. Executive Summary
5. Voice of Customer
5.1. Brand Awareness
5.2. Commonly Sold Over the Counter (OTC) Drugs, By Product
5.3. Preferred Point of Purchase
5.4. Unmet Needs/Challenges
6. Global Over the Counter (OTC) Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Product (Cough, Cold & Flu, Vitamins, Mineral, and Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others)
6.2.2. By Route of Administration (Oral, Parenteral, Topical, Others)
6.2.3. By Dosage Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others)
6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Region
6.2.6. By Company (2020)
6.3. Product Market Map
7. North America Over the Counter (OTC) Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Route of Administration
7.2.3. By Dosage Form
7.2.4. By Distribution Channel
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Over the Counter (OTC) Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Route of Administration
7.3.1.2.3. By Dosage Form
7.3.1.2.4. By Distribution Channel
7.3.2. Canada Over the Counter (OTC) Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Route of Administration
7.3.2.2.3. By Dosage Form
7.3.2.2.4. By Distribution Channel
7.3.3. Mexico Over the Counter (OTC) Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Route of Administration
7.3.3.2.3. By Dosage Form
7.3.3.2.4. By Distribution Channel
8. Europe Over the Counter (OTC) Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Route of Administration
8.2.3. By Dosage Form
8.2.4. By Distribution Channel
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Over the Counter (OTC) Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Route of Administration
8.3.1.2.3. By Dosage Form
8.3.1.2.4. By Distribution Channel
8.3.2. United Kingdom Over the Counter (OTC) Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Route of Administration
8.3.2.2.3. By Dosage Form
8.3.2.2.4. By Distribution Channel
8.3.3. Italy Over the Counter (OTC) Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Route of Administration
8.3.3.2.3. By Dosage Form
8.3.3.2.4. By Distribution Channel
8.3.4. Spain Over the Counter (OTC) Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Route of Administration
8.3.4.2.3. By Dosage Form
8.3.4.2.4. By Distribution Channel
8.3.5. France Over the Counter (OTC) Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Route of Administration
8.3.5.2.3. By Dosage Form
8.3.5.2.4. By Distribution Channel
9. Asia-Pacific Over the Counter (OTC) Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Route of Administration
9.2.3. By Dosage Form
9.2.4. By Distribution Channel
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Over the Counter (OTC) Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Route of Administration
9.3.1.2.3. By Dosage Form
9.3.1.2.4. By Distribution Channel
9.3.2. India Over the Counter (OTC) Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Route of Administration
9.3.2.2.3. By Dosage Form
9.3.2.2.4. By Distribution Channel
9.3.3. Japan Over the Counter (OTC) Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Route of Administration
9.3.3.2.3. By Dosage Form
9.3.3.2.4. By Distribution Channel
9.3.4. Australia Over the Counter (OTC) Drugs Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Route of Administration
9.3.4.2.3. By Dosage Form
9.3.4.2.4. By Distribution Channel
9.3.5. South Korea Over the Counter (OTC) Drugs Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Route of Administration
9.3.5.2.3. By Dosage Form
9.3.5.2.4. By Distribution Channel
10. South America Over the Counter (OTC) Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Route of Administration
10.2.3. By Dosage Form
10.2.4. By Distribution Channel
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Over the Counter (OTC) Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Route of Administration
10.3.1.2.3. By Dosage Form
10.3.1.2.4. By Distribution Channel
10.3.2. Argentina Over the Counter (OTC) Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Route of Administration
10.3.2.2.3. By Dosage Form
10.3.2.2.4. By Distribution Channel
10.3.3. Colombia Over the Counter (OTC) Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Route of Administration
10.3.3.2.3. By Dosage Form
10.3.3.2.4. By Distribution Channel
11. Middle East and Africa Over the Counter (OTC) Drugs Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Route of Administration
11.2.3. By Dosage Form
11.2.4. By Distribution Channel
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. Saudi Arabia Over the Counter (OTC) Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Route of Administration
11.3.1.2.3. By Dosage Form
11.3.1.2.4. By Distribution Channel
11.3.2. South Africa Over the Counter (OTC) Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Route of Administration
11.3.2.2.3. By Dosage Form
11.3.2.2.4. By Distribution Channel
11.3.3. UAE Over the Counter (OTC) Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Route of Administration
11.3.3.2.3. By Dosage Form
11.3.3.2.4. By Distribution Channel
11.3.4. Kuwait Over the Counter (OTC) Drugs Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Product
11.3.4.2.2. By Route of Administration
11.3.4.2.3. By Dosage Form
11.3.4.2.4. By Distribution Channel
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends and Developments
14. Competitive Landscape
14.1. Johnson & Johnson
14.2. Bayer AG
14.3. Novartis AG
14.4. GlaxoSmithKline Plc.-Pfizer, Inc.
14.5. Sanofi S.A.
14.6. Perrigo Company Plc.
14.7. Reckitt Benckiser Group Plc.
14.8. Sun Pharmaceutical Industries Ltd.
14.9. The Procter & Gamble Company
14.10. Teva Pharmaceutical Industries Limited
14.11. Dr. Reddy’s Laboratories Ltd.
14.12. Zydus Takeda Healthcare Pvt. Ltd.
14.13. Mylan NV
14.14. Cipla Ltd.
14.15. Alkem Laboratories Limited
15. Strategic Recommendations16. About the Publisher & Disclaimer

List of Figures

Figure 1: Global Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 2: Global Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F
Figure 3: Global Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 4: Global Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 5: Global Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 6: Global Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 7: Global Over the Counter (OTC) Drugs Market Share, By Region, By Value, 2016-2026F
Figure 8: Global Over the Counter (OTC) Drugs Market Share, By Company, By Value, 2020
Figure 9: North America Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 10: North America Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F
Figure 11: North America Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 12: North America Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 13: North America Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 14: North America Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 15: North America Over the Counter (OTC) Drugs Market Share, By Country, By Value, 2016-2026F
Figure 16: United States Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 17: United States Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 18: United States Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 19: United States Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 20: United States Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 21: Canada Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 22: Canada Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 23: Canada Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 24: Canada Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 25: Canada Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 26: Mexico Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 27: Mexico Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 28: Mexico Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 29: Mexico Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 30: Mexico Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 31: Europe Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 32: Europe Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F
Figure 33: Europe Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 34: Europe Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 35: Europe Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 36: Europe Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 37: Europe Over the Counter (OTC) Drugs Market Share, By Country, By Value, 2016-2026F
Figure 38: Germany Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 39: Germany Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 40: Germany Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 41: Germany Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 42: Germany Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 43: United Kingdom Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 44: United Kingdom Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 45: United Kingdom Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 46: United Kingdom Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 47: United Kingdom Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 48: Italy Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 49: Italy Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 50: Italy Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 51: Italy Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 52: Italy Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 53: Spain Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 54: Spain Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 55: Spain Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 56: Spain Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 57: Spain Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 58: France Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 59: France Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 60: France Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 61: France Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 62: France Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 63: Asia Pacific Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 64: Asia Pacific Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F
Figure 65: Asia Pacific Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 66: Asia Pacific Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 67: Asia Pacific Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 68: Asia Pacific Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 69: Asia Pacific Over the Counter (OTC) Drugs Market Share, By Country, By Value, 2016-2026F
Figure 70: China Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 71: China Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 72: China Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 73: China Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 74: China Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 75: India Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 76: India Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 77: India Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 78: India Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 79: India Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 80: Japan Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 81: Japan Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 82: Japan Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 83: Japan Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 84: Japan Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 85: Australia Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 86: Australia Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 87: Australia Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 88: Australia Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 89: Australia Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 90: South Korea Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 91: South Korea Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 92: South Korea Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 93: South Korea Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 94: South Korea Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 95: South America Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 96: South America Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F
Figure 97: South America Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 98: South America Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 99: South America Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 100: South America Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 101: South America Over the Counter (OTC) Drugs Market Share, By Country, By Value, 2016-2026F
Figure 102: Brazil Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 103: Brazil Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 104: Brazil Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 105: Brazil Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 106: Brazil Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 107: Argentina Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 108: Argentina Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 109: Argentina Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 110: Argentina Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 111: Argentina Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 112: Colombia Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 113: Colombia Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 114: Colombia Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 115: Colombia Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 116: Colombia Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 117: Middle East & Africa Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 118: Middle East & Africa Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F
Figure 119: Middle East & Africa Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 120: Middle East & Africa Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 121: Middle East & Africa Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 122: Middle East & Africa Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 123: Middle East & Africa Over the Counter (OTC) Drugs Market Share, By Country, By Value, 2016-2026F
Figure 124: Saudi Arabia Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 125: Saudi Arabia Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 126: Saudi Arabia Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 127: Saudi Arabia Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 128: Saudi Arabia Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 129: South Africa Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 130: South Africa Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 131: South Africa Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 132: South Africa Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 133: South Africa Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 134: UAE Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 135: UAE Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 136: UAE Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 137: UAE Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 138: UAE Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 139: Kuwait Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 140: Kuwait Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F
Figure 141: Kuwait Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 142: Kuwait Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F
Figure 143: Kuwait Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Johnson & Johnson
  • Bayer AG
  • Novartis AG
  • GlaxoSmithKline Plc.-Pfizer, Inc.
  • Sanofi S.A.
  • Perrigo Company Plc.
  • Reckitt Benckiser Group Plc.
  • Sun Pharmaceutical Industries Ltd.
  • The Procter & Gamble Company
  • Teva Pharmaceutical Industries Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Zydus Takeda Healthcare Pvt. Ltd.
  • Mylan NV
  • Cipla Ltd.
  • Alkem Laboratories Limited
Note: Product cover images may vary from those shown